Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Anavex Life Sciences Corp. Stock Price (Quote) NASDAQ:AVXL
$17.86 ( 0.11% ) Monday, 25th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $16.69 | $19.81 | Monday, 25th Oct 2021 AVXL stock ended at $17.86. This is 0.11% more than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 3.06% from a day low at $17.65 to a day high of $18.19. |
| 90 days | $16.55 | $21.99 | |
| 52 weeks | $4.52 | $31.50 |
Historical Anavex Life Sciences Corp. prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-25 | $17.78 | $18.19 | $17.65 | $17.86 | 436 328 |
| 2021-10-22 | $17.84 | $17.88 | $17.28 | $17.84 | 538 962 |
| 2021-10-21 | $17.91 | $18.28 | $17.85 | $17.98 | 647 627 |
| 2021-10-20 | $18.00 | $18.44 | $17.80 | $17.88 | 509 503 |
| 2021-10-19 | $17.94 | $18.33 | $17.82 | $18.00 | 688 776 |
| 2021-10-18 | $17.35 | $17.87 | $17.18 | $17.76 | 576 451 |
| 2021-10-15 | $18.12 | $18.12 | $17.50 | $17.52 | 483 039 |
| 2021-10-14 | $17.86 | $18.21 | $17.73 | $17.84 | 406 335 |
| 2021-10-13 | $17.27 | $17.90 | $17.25 | $17.67 | 427 433 |
| 2021-10-12 | $16.91 | $17.35 | $16.70 | $17.24 | 492 812 |
| 2021-10-11 | $17.27 | $17.28 | $16.76 | $16.88 | 654 252 |
| 2021-10-08 | $17.44 | $17.76 | $17.15 | $17.22 | 412 294 |
| 2021-10-07 | $17.27 | $17.72 | $16.69 | $17.42 | 613 379 |
| 2021-10-06 | $17.42 | $17.76 | $16.82 | $16.93 | 660 432 |
| 2021-10-05 | $17.33 | $17.92 | $17.24 | $17.63 | 541 548 |
| 2021-10-04 | $17.72 | $17.78 | $17.06 | $17.30 | 549 703 |
| 2021-10-01 | $18.36 | $18.36 | $17.22 | $17.95 | 882 234 |
| 2021-09-30 | $17.82 | $18.26 | $17.42 | $17.95 | 1 508 938 |
| 2021-09-29 | $18.45 | $18.67 | $17.67 | $17.82 | 717 711 |
| 2021-09-28 | $18.66 | $18.82 | $18.33 | $18.41 | 723 244 |
| 2021-09-27 | $18.62 | $19.81 | $18.51 | $19.23 | 803 512 |
| 2021-09-24 | $19.16 | $19.36 | $18.48 | $18.74 | 1 154 238 |
| 2021-09-23 | $18.09 | $19.38 | $17.79 | $19.29 | 1 025 864 |
| 2021-09-22 | $17.44 | $17.85 | $16.98 | $17.64 | 631 560 |
| 2021-09-21 | $17.00 | $17.85 | $16.87 | $17.40 | 806 021 |
| 2021-09-20 | $17.00 | $17.42 | $16.55 | $16.87 | 913 810 |
| 2021-09-17 | $17.07 | $17.80 | $16.80 | $17.63 | 1 638 728 |
| 2021-09-16 | $17.09 | $17.27 | $16.66 | $16.97 | 742 134 |
| 2021-09-15 | $16.84 | $17.36 | $16.71 | $17.07 | 1 053 034 |
| 2021-09-14 | $18.15 | $18.31 | $16.77 | $16.82 | 1 330 476 |
| 2021-09-13 | $18.75 | $18.76 | $18.05 | $18.13 | 730 852 |
| 2021-09-10 | $19.00 | $19.32 | $18.67 | $18.70 | 576 552 |
| 2021-09-09 | $18.60 | $19.62 | $18.46 | $18.91 | 762 161 |
| 2021-09-08 | $19.11 | $19.15 | $18.30 | $18.63 | 683 631 |
| 2021-09-07 | $19.47 | $20.29 | $19.02 | $19.14 | 821 225 |
| 2021-09-03 | $19.87 | $20.07 | $19.11 | $19.48 | 743 714 |
| 2021-09-02 | $20.25 | $20.65 | $19.66 | $19.97 | 682 589 |
| 2021-09-01 | $19.31 | $20.34 | $18.96 | $20.22 | 1 000 207 |
| 2021-08-31 | $18.65 | $20.19 | $18.56 | $19.49 | 1 798 917 |
| 2021-08-30 | $18.83 | $19.19 | $18.31 | $18.54 | 726 915 |
| 2021-08-27 | $18.50 | $19.32 | $18.11 | $19.03 | 943 416 |
| 2021-08-26 | $19.34 | $19.78 | $18.53 | $18.55 | 764 927 |
| 2021-08-25 | $18.78 | $19.79 | $18.65 | $19.04 | 885 853 |
| 2021-08-24 | $20.15 | $20.27 | $18.96 | $19.40 | 1 206 747 |
| 2021-08-23 | $18.68 | $19.77 | $18.53 | $19.72 | 899 140 |
| 2021-08-20 | $18.22 | $18.77 | $18.03 | $18.36 | 839 066 |
| 2021-08-19 | $18.51 | $18.96 | $18.25 | $18.29 | 792 775 |
| 2021-08-18 | $19.18 | $19.59 | $18.64 | $18.81 | 679 597 |
| 2021-08-17 | $18.88 | $19.48 | $18.53 | $19.33 | 786 083 |
| 2021-08-16 | $19.31 | $19.46 | $18.42 | $19.00 | 989 701 |
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimers disease, other central nervous system diseases, pain, and various cancers. The companys lead drug candidates include ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil, which is in a Phase 2a clinical trial for the treatment of Alzheimers and other central nervous system ... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
